Dr. Stephen Patrick Bergin, MD

Dr. Bergin practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Bergin's NPI, 1801030507, was assigned on April 24, 2009. Dr. Bergin graduated from University of Mississippi Medical Center - Jackson in 2009. Dr. Bergin's North Carolina license number on file is 2012-00127.

Dr. Bergin's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Bergin's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Bergin is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Bergin to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergin practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bergin's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bergin is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Bergin has a license on file in North Carolina.

Dmand AI lists asthma, atrial fibrillation and flutter, chronic lung disease, chronic obstructive pulmonary disease (COPD), heart failure, heart valve disorders, larynx and vocal cord disease and pneumonia among the conditions Dr. Bergin treats.

CMS data shows 287 Medicare services from Dr. Bergin across 6 procedure codes in 2024, for 145 Medicare patients. Medicare paid $29,306 for them.

CMS counts 145 Medicare patients who saw Dr. Bergin in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bergin's median patient age at 70, with 53% women.

In 2022, Dr. Bergin wrote 30 Medicare Part D claims. They cover 2 drugs, with $151,972 in total drug cost. In 2021, CMS named 100 claims across 6 drugs.

Dr. Bergin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Bergin, published from 2016 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Pneumonia and Bacteremia. Dr. Bergin has published most often in Clin Infect Dis. Dr. Bergin's most frequent co-authors are Vance G. Fowler, MD, Ephraim Lee Tsalik, MD, PhD and Christina Eleanor Barkauskas, MD.

Dmand AI links Dr. Bergin to 1 clinical trial. Conditions studied include Pneumonia, Bacterial and Bacterial Infections.

CMS Open Payments shows 14 general payments to Dr. Bergin from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 98% of the total. Medtronic, Inc. paid the most, $619.

Dmand AI lists 8 awards for Dr. Bergin, most recently International Conference Abstract Scholarship in 2017.

Dr. Bergin graduated from University of Mississippi Medical Center - Jackson in 2009. Dr. Bergin is a member of ACCP and ATS.

Dr. Bergin is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.